INSIDIOUS ISRAELI SCIENTISTS design “Black Death” mutant plague mRNA injections that turn human cells into Frankenstein mutations

Governments around the world are funding scientists to create the next deadly plandemic and nobody is trying to stop them. This is ludicrous. It’s criminal. For example, Israeli military scientists have genetically engineered a mutant form of Yersinia pestis, the bacterium responsible for the plague, and used its virulence genes to create a new mRNA vaccine. The research, conducted by the Israel Institute for Biological Research (IIBR), has sparked global alarm due to its implications for biowarfare, bioethics, and vaccine safety.

• Israeli Scientists Engineer Mutant Plague mRNA Vaccine: Military researchers at Israel’s Institute for Biological Research genetically modified the Yersinia pestis bacterium (causative agent of plague) and developed an mRNA vaccine that instructs human cells to produce two key plague proteins—one mimicking immune suppression, the other evading immune detection.
• Use of Controversial mRNA Ingredient (m1?): The vaccine uses N1-methyl-pseudouridine (m1?), a synthetic nucleotide linked to rogue protein production, autoimmune reactions, and cancer growth—already flagged as a safety concern in COVID-19 mRNA vaccine studies.
• Global Biowarfare Concerns and Legal Loopholes: Israel’s work was conducted outside the Biological Weapons Convention, which the nation has not ratified, raising alarm about international legal oversight, especially as plague was recently added to the WHO’s pandemic watchlist.
• Bioethics and Safety Questions Intensify: Critics argue the project blurs the line between biodefense and biowarfare by normalizing the use of genetically engineered Tier 1 bioweapons in vaccines, potentially endangering public health under the banner of pandemic preparedness.

Israel Engineers Mutant Plague: mRNA Jab Turns Human Cells Into ‘Black Death’ Protein Factories

The genetically altered strain, known as F1? Kimberley53, was developed by deleting the caf1 gene from a fully virulent plague variant, thereby removing the bacterium’s immune-shielding capsule. This modified strain was designed to simulate a “vaccine escape” pathogen—one that could potentially circumvent immune defenses. Researchers then extracted genetic segments from this engineered plague and inserted them into a dual-component mRNA vaccine.

This vaccine contains synthetic mRNA instructions for producing two modified plague proteins:

1. LcrV – a virulence protein used by Y. pestis to suppress immune responses and infect human cells.
2. F1 – a protein that normally forms a capsule around the bacterium to shield it from immune detection.

Both proteins were further fused with a human antibody domain (Fc region) to enhance stability and immune response. The mRNA was chemically altered with N1-methyl-pseudouridine (m1?), a synthetic nucleotide also used in COVID-19 vaccines. While m1? increases mRNA longevity and protein output, studies have linked it to immune evasion, autoimmune responses, and even accelerated tumor growth.

Critics argue that this research, carried out under the banner of pandemic preparedness and biodefense, treads dangerously close to violating international bioweapons laws. Israel, notably, is not a signatory of the Biological Weapons Convention, and the IIBR has long been associated with military-grade biological research. Despite this, the study was peer-reviewed and supported by the European Research Council and the EU’s Horizon 2020 program.

Legal and ethical experts warn that the Israeli team’s approach—engineering a mutant version of the plague and using its virulence mechanisms to program human cells—raises profound biosecurity and ethical concerns. These include the potential misuse of the technology, the risks of accidental release, and the health dangers posed by synthetic mRNA vaccines that direct human cells to produce harmful bacterial proteins.

The use of m1? in this platform is especially concerning, as multiple studies have highlighted its role in creating “rogue” proteins through genetic frameshifts and in promoting cancer metastasis. Critics argue that this adds another layer of risk, especially as booster doses accumulate in individuals.

This project marks a troubling intersection of biotechnology, military interests, and global health policy. It also sets a precedent for normalizing the use of genetically engineered Tier 1 pathogens—those classified as top-level bioterrorism threats—in vaccine development. While intended as a defensive measure, the manipulation of plague genes for insertion into human cells via mRNA platforms underscores the growing threat of dual-use research, where the line between medical innovation and biowarfare becomes increasingly blurred.

Bookmark Vaccines.news to your favorite independent websites for updates on experimental gene therapy injections like mRNA clot shots that lead to early death, infertility, turbo cancer and Long-Vax-Syndrome.

Sources for this article include:

Pandemic.news

NaturalNews.com

Modernity.news